Updates
** New Zealand's Fisher & Paykel Healthcare FPH.NZ falls 1.7% to NZ$36.13, loses 0.8% for the week
** Stock set for weakest week since April 5
** Jefferies downgrades to "hold" from "buy", keeps PT unchanged at NZ$39.40
** Says it's interested in knowing impact of U.S. tariffs to date, when co reports FY25 results on May 28; will closely watch co's mitigation strategies
** Notes, "We understand the primary impact on FPH imports is currently a 10% tariff on New Zealand products"
** Stock rated "hold" on avg; median PT is NZ$35.81, per data compiled by LSEG
** YTD, FPH falls ~6%
(Reporting by Roshan Thomas and Nikita Maria Jino in Bengaluru)
((Roshan.Thomas@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。